Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1
Public ClinicalTrials.gov record NCT03673007. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Michigan Contraceptive Access, Research, and Evaluation Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
M-CARES will use large-scale administrative data complemented by follow-up surveys and a randomized control trial (RCT) to estimate the causal impact of greater financial access to contraception on a comprehensive set of outcomes. Outcomes include contraceptive use, pregnancy, childbearing, and parenting strategies; partnership decisions and relationship quality; health and health care use; education, labor market success, and public assistance receipt; financial security; neighborhood quality; mental health and stress; and life plans. The resulting estimates will inform a more complete understanding of the costs and benefits of financial access to contraception and, therefore, the investment value of related policies and programs.
Study identification
- NCT ID
- NCT03673007
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 4,633 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 35 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 25, 2018
- Primary completion
- Dec 30, 2028
- Completion
- Dec 30, 2028
- Last update posted
- Jun 1, 2026
2018 – 2028
United States locations
- U.S. sites
- 9
- U.S. states
- 1
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Planned Parenthood - Ann Arbor-West | Ann Arbor | Michigan | 48103 | — |
| Planned Parenthood - Detroit | Detroit | Michigan | 48201 | — |
| Planned Parenthood - Ferndale | Ferndale | Michigan | 48220 | — |
| Planned Parenthood - Grand Rapids | Grand Rapids | Michigan | 49503 | — |
| Planned Parenthood - Kalamazoo | Kalamazoo | Michigan | 49006 | — |
| Planned Parenthood - Lansing | Lansing | Michigan | 48912 | — |
| Planned Parenthood - Livonia | Livonia | Michigan | 48154 | — |
| Planned Parenthood - Traverse City | Traverse City | Michigan | 49686 | — |
| Planned Parenthood - Warren | Warren | Michigan | 48093 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03673007, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03673007 live on ClinicalTrials.gov.